Freudenberg Medical‘s VistaMed today said it is a part of a team that was awarded €5.1 million ($6 million) over a three-year period to develop a catheter to improve treatment of cardiac arrhythmia.
VistaMed, along with OneProjects and the Tyndall Institute, received the grant sponsored by the Irish government through the Disruptive Technology & Innovation Fund. The consortium of the three companies will use the funds to develop a catheter to deliver direct 3D, intraprocedural analysis of the success of cardiac ablation during atrial fibrillation treatment.
Get the full story on our sister site, Medical Tubing + Extrusion.